Cerebrolysin and Neurodevelopment in Preterm Infants
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The overall aim of the study is to assess the effect of Cerebrolysin on physical and mental
development of preterm infants by Denver Scale II at different ages of 5, 7 and 12 months